AzTrials
AzTrials

Mild Cognitive ImpairmentNCT03375151

An Examination of the Use of Electrophysiological Brain Monitoring to Direct the Treatment of Mild Cognitive Impairment

A study testing EEG based feedback, Standard practice based feedback and No feedback in people with Mild Cognitive Impairment, run by Brainmarc Ltd..

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The problem of cognitive decline among the aging population has become a significant health burden, especially in light of the increase in the prevalence of dementia with age For patients with MCI (Mild cognitive impairment) there are various recommendations to deal with the disorder, including behavioral… Read more about this study

Who is it for?
Ages 65 to 120 years
Conditions the study is for
Mild Cognitive Impairment
What is being tested?
EEG based feedback, Standard practice based feedback and No feedback
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
No sites listed yet
Study dates
Feb 2018to Apr 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 to 120 years
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Male or female above the age of 65 years
  • Ability to read, write and understand the Hebrew language so to comply with study demands.
  • Diagnosed with Amnestic MCI. Mini Mental State Examination (MMSE), A score of MSSE ≥27 for college educated subjects and MSSE ≥ 26 for all others; and (CDR) Clinical Dementia Rating, 0.5 ≥ CDR
  • Diagnosed with memory impairment, Visual Paired Association = VPA (WMS-R), for subjects of ages 65-70, 16.5 ≥ WMS-R and for subjects of age above 71, 15.5 ≥ WMS-R

Who cannot join

  • Diagnosed with major psychiatric or neurological disorder.
  • A user of recreational or illicit drugs or has had a recent history of drug or alcohol abuse or dependence.

Trial locations and contacts

No sites are listed yet.

Goded Shahaf, Dr. contact

97246660676

goded@brainmarc.com

About this study

The problem of cognitive decline among the aging population has become a significant health burden, especially in light of the increase in the prevalence of dementia with age For patients with MCI (Mild cognitive impairment) there are various recommendations to deal with the disorder, including behavioral recommendations for physical exercise. Some recommendations could also be found for cognitive practice. However, currently, there is no consensus regarding effective cognitive treatment or practice for MCI. Among the populations suffering from MCI, there is a significant segment of patients with amnestic disorder. For these patients, it seems that cognitive training of memory, including verbal memory, is very important. In recent years, we have developed an effective tool for managing rehabilitation practice by monitoring the patient's engagement with an easy-to-use EEG (electroencephalogram) tool. We have shown in a variety of rehabilitation settings, that when the patient is recruited, the clinical improvement is significantly better. The aim of this study is to evaluate the ability to harness the EEG monitoring of brain engagement to achieve functional improvement in verbal memory training in patients with Amnestic MCI.

Being tested
EEG based feedback, Standard practice based feedback, No feedback
Medical subject headings
Cognitive Dysfunction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • EEG based feedbackDevice

    Participants will participate in cognitive training sessions. The therapist will use feedback from the EEG analyzed data to direct the cognitive therapy based on the therapist's guidance to maximize the intensity and duration of the patient's high brain engagement Index (BEI) during exercise.

  • Standard practice based feedbackBehavioural

    Participants will participate in cognitive training sessions. The therapist will give feedback to the participants during the exercise based on their performance only according to the his therapist standard practice.

  • No feedbackBehavioural

    Participants will participate in cognitive training sessions. The therapist will not guide them during the sessions.

Study groups in NCT03375151
Study groupRoleWhat they receive
EEG based feedbackExperimentalThe therapist will give feedback to the participants during the exercise based on their performance.and use the feedback from the EEG analyzed data to direct cognitive therapy based on the therapist's guidance to maximize the intensity and duration of the patient's high brain engagement Index (BEI) during exercise.
Receives: Device: EEG based feedback; Behavioral: Standard practice based feedback
Standard practice based feedbackOtherThe therapist will give feedback to the participants during the exercise based on their performance.
Receives: Behavioral: Standard practice based feedback
No feedbackOtherThe participants will perform the exercise without feedback during practice.
Receives: Behavioral: No feedback

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cognitive test grade

    The difference in grades in a test for evaluation cognitive abilities in a textual assignment between the beginning and the end of the study.

    Measured: up to 5 weeks

Secondary outcomes (4)
  1. Rey Auditory-Verbal Learning Test

    The difference in grades of Free And Cued Selective Reminding Test (FCSRT) score between the beginning and the end of the study.

    Measured: up to 5 weeks

  2. Free And Cued Selective Reminding Test

    The difference in grades of Rey Auditory-Verbal Learning Test (RAVLT) score between the beginning and the end of the study.

    Measured: up to 5 weeks

  3. Rivermead Behavioral Memory Test

    The difference in grades of Rivermead Behavioral Memory Test (RBMT) score between the beginning and the end of the study.

    Measured: up to 5 weeks

  4. Clinical Global Impression of Change

    The difference in grades of Clinical Global Impression of Change (CGI-C) score between the beginning and the end of the study.

    Measured: up to 5 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Dec 2017
  2. Study startFeb 2018 (estimated)
  3. Primary completionFeb 2019 (estimated)
  4. Study completionApr 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03375151
Sponsor's protocol ID
CLD13
Status last verified
Dec 2017
First submitted
13 Dec 2017
Last updated
15 Dec 2017
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing EEG based feedback, Standard practice based feedback and No feedback in people with Mild Cognitive Impairment, run by Brainmarc Ltd..

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 15 Dec 2017. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Goded Shahaf, Dr. (97246660676, goded@brainmarc.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cognitive test grade (time frame: up to 5 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Dec 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in